封面
市場調查報告書
商品編碼
2026901

Western Blotting市場預測至2034年-按產品、應用、最終用戶和地區分類的全球分析

Western Blotting Market Forecasts to 2034 - Global Analysis By Product (Consumables, Instruments and Other Products), Application (Clinical Diagnostics, Food & Beverages and Other Applications), End User and By Geography

出版日期: | 出版商: Stratistics Market Research Consulting | 英文 | 商品交期: 2-3個工作天內

價格

根據 Stratistics MRC 的數據,預計到 2026 年,全球蛋白質印跡市場規模將達到 15.2 億美元,並在預測期內以 8.7% 的複合年成長率成長,到 2034 年將達到 29.5 億美元。

蛋白質分析和檢測是分子生物學技術-蛋白質印跡法(Western blotting)的常見應用。此方法首先利用凝膠電泳將蛋白質依大小分離,然後將分離的蛋白質轉移到膜上。蛋白質印跡法廣泛應用於眾多科學領域,用於研究蛋白質表現、轉譯後修飾和相互作用。

根據美國疾病管制與預防中心(CDC)公佈的數據,2020 年美國有 30635 人被診斷出感染 HIV。

對生物醫學研究的需求日益成長

蛋白質印跡法極大地促進了細胞過程、蛋白質表現和相互作用的研究,為神經生物學和腫瘤學等領域帶來了重要的全新見解。隨著生物醫學研究領域的拓展和對精確蛋白質分析需求的日益成長,蛋白質印跡法已成為不可或缺的工具。此外,其在闡明疾病、理解分子機制和檢驗研究結果方面的多功能性,西方印漬術成為一項基礎性工具,並透過滿足生物醫學研究界不斷變化的需求,推動了該市場的發展和創新。

前期成本高

Western blotting 的成本主要來自多個方面,包括使用昂貴的試劑和耗材,例如封閉劑、檢測基材和抗體。成像設備和凝膠電泳系統等專用設備也會增加總成本。此外,對熟練操作人員的需求也進一步推高了這項技術的成本。高昂的檢測成本是限制市場成長的一大障礙。

政府措施和支持

美國國立衛生研究院 (NIH) 等政府機構正在資助利用蛋白質印跡技術進行的計畫。這種支持正在加速創新、技術進步以及生物醫學、藥物研發和診斷等領域新應用的研究。此外,這種資金支持正在為蛋白質分析及相關研究的發展創造有利環境,透過改善技術應用,加速科學發現並促進市場擴張。

缺乏標準化

不同實驗室間操作流程、試劑和設備的不相容性會阻礙結果的重複性。調查方法的差異會影響數據的可靠性,使研究人員難以比較和檢驗研究結果。標準化問題會影響蛋白質印跡法的評估,引發人們對數據準確性的質疑,並使研究團隊之間的合作更具挑戰性。

新型冠狀病毒(COVID-19)的影響

供應鏈中斷、物流挑戰以及實驗室活動限制阻礙了蛋白質印跡試劑和設備的生產和分銷。封鎖措施導致許多研究項目延期或暫停,進而影響了對這些產品的需求。此外,非新冠肺炎相關研究經費的減少也限制了可用於蛋白質印跡研究的資源。最終,研究重點轉向新冠肺炎導致其他領域的關注和資源被轉移。經濟的不確定性加劇了人們對成本的擔憂,進而影響了科學界的採購決策。

在預測期內,設備細分市場預計將是規模最大的。

由於其在分子生物學和蛋白質研究中發揮著至關重要的作用,儀器設備領域預計將佔據最大的市場佔有率。這些儀器在從複雜的生物樣本中精確分離、轉錄和檢測蛋白質方面發揮關鍵作用。製造商不斷創新,透過整合高速電泳、半乾式或濕式轉錄功能以及先進的成像技術等特性,為研究人員提供最先進的系統。此外,這些儀器還包括用於根據大小分離蛋白質的電泳系統、用於轉移蛋白質的轉錄系統以及用於可視化和定量蛋白質條帶的成像系統,這些都推動了該領域的擴張。

預計在預測期內,生物製藥和生技公司板塊的複合年成長率將最高。

由於這些儀器在藥物研發、品管和研究方法中的蛋白質分析應用廣泛,因此預計生物製藥和生物技術公司板塊在預測期內將呈現最高的複合年成長率。此技術有助於評估蛋白質表現、檢驗治療標靶並確保產品一致性。此外,它透過提供精準的蛋白質表徵訊息,推動生物製藥開發和生物技術研究的進步。該板塊是生物製藥開發和生產的關鍵相關人員群體,因此也是推動其成長的主要動力。

市佔率最大的地區:

在預測期內,北美佔據了最大的市場佔有率,這主要得益於政府對生物技術和醫療保健領域研發的支持項目。學術機構、研究組織和產業相關人員之間的合作正在推動創新和應用。此外,這些合作如今已符合美國食品藥物管理局(FDA) 等機構制定的法規結構所設定的品質標準,確保了研究和診斷的可靠性,從而擴大了該地區的市場規模。

複合年成長率最高的地區:

預計在預測期內,歐洲將錄得最高的複合年成長率,這主要得益於生命科學研究中檢測技術、轉錄策略和凝膠電泳系統的進步。這些方法如今更加精準高效,而歐洲促進研發的政策以及支持生物技術和醫療保健創新的舉措進一步推動了這一成長。博斯特生物技術公司、通用電氣醫療集團、珀金埃爾默公司和丹納赫公司等領先企業為該地區嚴格的監管政策和品質標準的建立做出了貢獻,這些政策和標準正在推動該地區的成長。

免費客製化服務:

所有購買此報告的客戶均可享受以下免費自訂選項之一:

  • 企業概況
    • 對其他市場參與者(最多 3 家公司)進行全面分析
    • 對主要公司進行SWOT分析(最多3家公司)
  • 區域分類
    • 應客戶要求,我們提供主要國家和地區的市場估算和預測,以及複合年成長率(註:需進行可行性檢查)。
  • 競爭性標竿分析
    • 根據產品系列、地理覆蓋範圍和策略聯盟對重點公司進行基準分析。

目錄

第1章執行摘要

第2章:引言

  • 概括
  • 相關利益者
  • 調查範圍
  • 調查方法
  • 研究材料

第3章 市場趨勢分析

  • 促進因素
  • 抑制因子
  • 機會
  • 威脅
  • 產品分析
  • 應用分析
  • 最終用戶分析
  • 新興市場
  • 新冠疫情的感染疾病

第4章:波特五力分析

  • 供應商的議價能力
  • 買方的議價能力
  • 替代品的威脅
  • 新進入者的威脅
  • 競爭公司之間的競爭

第5章:全球蛋白質印跡市場:依產品分類

  • 消耗品
    • 試劑和緩衝溶液
    • 抗體和結合物
      • 二抗
      • 一抗
    • 成套工具
    • 膜和濾紙
    • 其他消耗品
  • 裝置
    • 印跡系統
      • 濕式吸墨系統
      • 半驅動腐蝕系統
    • 電泳裝置
    • 成像器
      • 螢光成像器
      • 化學冷光成像器
  • 其他產品

第6章:全球蛋白質印跡市場:依應用分類

  • 臨床診斷
    • 萊姆病
    • 肝炎
    • 人類免疫力缺乏病毒(HIV)
    • 其他臨床診斷
  • 食品/飲料
  • 其他用途

第7章:全球蛋白質印跡市場:依最終用戶分類

  • 醫院
  • 生物製藥和生物技術公司
  • 學術研究機構
  • 其他最終用戶

第8章:全球蛋白質印跡市場:按地區分類

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 義大利
    • 法國
    • 西班牙
    • 其他歐洲國家
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 紐西蘭
    • 韓國
    • 其他亞太國家
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 其他南美國家
  • 中東和非洲
    • 沙烏地阿拉伯
    • UAE
    • 卡達
    • 南非
    • 其他中東和非洲國家

第9章 主要發展

  • 合約、夥伴關係、合作關係、合資企業
  • 收購與併購
  • 新產品發布
  • 業務拓展
  • 其他關鍵策略

第10章:公司簡介

  • Abcam Plc
  • Advansta, Inc.
  • Azure biosystems, inc.
  • Bio-Techne Corporation
  • Boster Biological Technology
  • Cell signaling technology, inc.
  • Danaher Corporation
  • EMD Millipore Corporation
  • GE Healthcare
  • Hofmann-La Roche Ltd.
  • LI-COR, Inc.
  • Merck Kgaa
  • PerkinElmer Inc.
  • Stressmarq biosciences inc.
  • Thermo Fisher Scientific, Inc.
Product Code: SMRC24682

According to Stratistics MRC, the Global Western Blotting Market is accounted for $1.52 billion in 2026 and is expected to reach $2.95 billion by 2034 growing at a CAGR of 8.7% during the forecast period. Protein analysis and detection are common applications of the molecular biology technique known as western blotting. It involves transferring the separated proteins onto a membrane after they have been separated by size using gel electrophoresis. Numerous scientific domains utilize western blotting to aid in the investigation of protein expression, post-translational modifications, and interactions.

According to data published by the Centers for Disease Control and Prevention (CDC), stated that in 2020, 30,635 people received an HIV diagnosis in the U.S.

Market Dynamics:

Driver:

Increase in biomedical research demand

The study of cellular processes, protein expression, and interactions is greatly aided by western blotting, which provides important new understandings in fields like neurobiology and cancer. It is essential as the field of biomedical research grows and the need for precise protein analysis increases. Furthermore, its versatility in exploring diseases, understanding molecular mechanisms, and validating research findings positions it as a fundamental tool, to meet the evolving demands of the biomedical research community which is driving adoption and innovation of this market's growth.

Restraint:

High initial cost

The cost of Western blotting can be attributed to several reasons, such as the fact that the procedure necessitates the use of costly reagents and consumables, including blocking agents, detection substrates, and antibodies. Specialized tools like imaging equipment and gel electrophoresis systems also raise the overall cost. Furthermore, the cost of using the technique is further increased by the requirement for skilled personnel. The high expense of carrying out these tests is one significant obstacle to the market.

Opportunity:

Government initiatives and support

Initiatives from government bodies, such as the National Institutes of Health (NIH), allocate funds to projects involving Western blotting techniques. Innovation, technical progress, and the investigation of novel uses in biomedicine, medication development, and diagnostics are all encouraged by this support. Furthermore, the financial support creates a favorable environment for developments in protein analysis and related research, speeds up scientific discoveries, and supports by improving accessibility which is driving this market expansion.

Threat:

Lack of standardization

Incompatibilities across laboratories in procedures, reagents, and equipment hinder result reproducibility. Variability in methodologies impacts data reliability, making it challenging for researchers to compare and validate findings. Problems with standardization can damage Western blotting's image, raising doubts regarding the accuracy of the data and making it more difficult for research groups to collaborate.

Covid-19 Impact

Disruptions in supply chains, logistical challenges, and restrictions on laboratory activities have hindered the production and distribution of Western blotting reagents and instruments. Many research projects were delayed or halted due to lockdowns, impacting the demand for these products. Furthermore, the resources available for Western blotting studies have been restricted due to decreased funding for research irrelevant to COVID-19. Eventually, attention and resources have been diverted from other areas due to the shift in research priorities towards COVID-19. Economic uncertainties have prompted cost-consciousness, affecting purchasing decisions in the scientific community.

The instruments segment is expected to be the largest during the forecast period

The instrument segment is estimated to hold the largest share due to its crucial role in molecular biology and protein research. They play a pivotal role in the precise separation, transfer, and detection of proteins from complex biological samples. Manufacturers continually innovate to provide researchers with state-of-the-art systems, incorporating features like rapid electrophoresis, semi-dry or wet transfer capabilities, and advanced imaging technologies. Furthermore, these instruments include electrophoresis systems for separating proteins based on size, transfer systems for transferring proteins, and imaging systems for visualizing and quantifying protein bands, which is driving this segment expansion.

The biopharmaceutical & biotechnology companies segment is expected to have the highest CAGR during the forecast period

The biopharmaceutical & biotechnology companies segment is anticipated to have highest CAGR during the forecast period due to the use of these companies for protein analysis in drug development, quality control, and research processes. The technique aids in assessing protein expression, validating therapeutic targets, and ensuring product consistency. Additionally, by providing precise insights into protein characteristics, it supports the development of biopharmaceuticals and the advancement of biotechnological research. It represents a key stakeholder group in the development and production of biotherapeutics, thereby boosting this segment's growth.

Region with largest share:

North America commanded the largest market share during the extrapolated period owing to government programs that support scientific research and development, especially in the biotechnology and healthcare sectors. Collaborations between academic institutions, research organizations, and industry players foster innovation and applications. Furthermore, these now meet quality standards set by regulatory frameworks established by organizations such as the Food and Drug Administration (FDA), guaranteeing dependability in research and diagnostics, thereby propelling this region's size.

Region with highest CAGR:

Europe is expected to witness highest CAGR over the projection period due to advancements in detection technologies, transfer strategies, and gel electrophoresis systems in life sciences research. These procedures are now more accurate and efficient European policies promoting research and development, coupled with initiatives supporting biotechnology and healthcare innovation. Some of the key players including Boster Biological Technology, GE Healthcare, PerkinElmer Inc. and Danaher Corporation contribute to strict regulatory policies and quality standards which are driving this region's growth.

Key players in the market

Some of the key players in the Western Blotting Market include Abcam Plc, Advansta, Inc., Azure biosystems, inc., Bio-Techne Corporation, Boster Biological Technology, Cell signaling technology, inc., Danaher Corporation, EMD Millipore Corporation, GE Healthcare, Hofmann-La Roche Ltd., LI-COR, Inc., Merck Kgaa, PerkinElmer Inc., Stressmarq biosciences inc. and Thermo Fisher Scientific, Inc.

Key Developments:

In November 2023, GE HealthCare and Masimo announced a joint agreement to integrate Masimo Signal Extraction Technology (SET) pulse oximetry into GE HealthCare's Portrait Mobile wireless and wearable patient monitoring solution.

In October 2023, Thermo Fisher Scientific and Olink announced that their respective boards of directors have approved Thermo Fisher's proposal to acquire Olink for $26.00 per common share in cash, representing $26.00 per American Depositary Share (ADS) in cash.

In October 2023, GE HealthCare Announces New Innovations and Collaborations in Image Guided Therapy as part of TCT2023 Cardiology Care Pathway Showcase. As clinicians work to treat CVD, cardiology procedures continue to evolve as demand for minimally invasive surgery grows.

Products Covered:

  • Consumables
  • Instruments
  • Other Products

Applications Covered:

  • Clinical Diagnostics
  • Food & Beverages
  • Other Applications

End Users Covered:

  • Hospitals
  • Biopharmaceutical & Biotechnology Companies
  • Academic & Research Institutes
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2023, 2024, 2025, 2026, 2027, 2028, 2030, 2032 and 2034
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Product Analysis
  • 3.7 Application Analysis
  • 3.8 End User Analysis
  • 3.9 Emerging Markets
  • 3.10 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Western Blotting Market, By Product

  • 5.1 Introduction
  • 5.2 Consumables
    • 5.2.1 Reagents & Buffers
    • 5.2.2 Antibodies & Conjugates
      • 5.2.2.1 Secondary Antibodies
      • 5.2.2.2 Primary Antibodies
    • 5.2.3 Kits
    • 5.2.4 Membranes & Filter Papers
    • 5.2.5 Other Consumables
  • 5.3 Instruments
    • 5.3.1 Blotting Systems
      • 5.3.1.1 Wet Blotting Systems
      • 5.3.1.2 Semi-dry Blotting Systems
    • 5.3.2 Electrophoresis Instruments
    • 5.3.3 Imagers
      • 5.3.3.1 Fluorescent Imagers
      • 5.3.3.2 Chemiluminescent Imagers
  • 5.4 Other Products

6 Global Western Blotting Market, By Application

  • 6.1 Introduction
  • 6.2 Clinical Diagnostics
    • 6.2.1 Lyme Disease
    • 6.2.2 Hepatitis
    • 6.2.3 Human Immunodeficiency Virus (HIV)
    • 6.2.4 Other Clinical Diagnostics
  • 6.3 Food & Beverages
  • 6.4 Other Applications

7 Global Western Blotting Market, By End User

  • 7.1 Introduction
  • 7.2 Hospitals
  • 7.3 Biopharmaceutical & Biotechnology Companies
  • 7.4 Academic & Research Institutes
  • 7.5 Other End Users

8 Global Western Blotting Market, By Geography

  • 8.1 Introduction
  • 8.2 North America
    • 8.2.1 US
    • 8.2.2 Canada
    • 8.2.3 Mexico
  • 8.3 Europe
    • 8.3.1 Germany
    • 8.3.2 UK
    • 8.3.3 Italy
    • 8.3.4 France
    • 8.3.5 Spain
    • 8.3.6 Rest of Europe
  • 8.4 Asia Pacific
    • 8.4.1 Japan
    • 8.4.2 China
    • 8.4.3 India
    • 8.4.4 Australia
    • 8.4.5 New Zealand
    • 8.4.6 South Korea
    • 8.4.7 Rest of Asia Pacific
  • 8.5 South America
    • 8.5.1 Argentina
    • 8.5.2 Brazil
    • 8.5.3 Chile
    • 8.5.4 Rest of South America
  • 8.6 Middle East & Africa
    • 8.6.1 Saudi Arabia
    • 8.6.2 UAE
    • 8.6.3 Qatar
    • 8.6.4 South Africa
    • 8.6.5 Rest of Middle East & Africa

9 Key Developments

  • 9.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 9.2 Acquisitions & Mergers
  • 9.3 New Product Launch
  • 9.4 Expansions
  • 9.5 Other Key Strategies

10 Company Profiling

  • 10.1 Abcam Plc
  • 10.2 Advansta, Inc.
  • 10.3 Azure biosystems, inc.
  • 10.4 Bio-Techne Corporation
  • 10.5 Boster Biological Technology
  • 10.6 Cell signaling technology, inc.
  • 10.7 Danaher Corporation
  • 10.8 EMD Millipore Corporation
  • 10.9 GE Healthcare
  • 10.10 Hofmann-La Roche Ltd.
  • 10.11 LI-COR, Inc.
  • 10.12 Merck Kgaa
  • 10.13 PerkinElmer Inc.
  • 10.14 Stressmarq biosciences inc.
  • 10.15 Thermo Fisher Scientific, Inc.

List of Tables

  • Table 1 Global Western Blotting Market Outlook, By Region (2023-2034) ($MN)
  • Table 2 Global Western Blotting Market Outlook, By Product (2023-2034) ($MN)
  • Table 3 Global Western Blotting Market Outlook, By Consumables (2023-2034) ($MN)
  • Table 4 Global Western Blotting Market Outlook, By Reagents & Buffers (2023-2034) ($MN)
  • Table 5 Global Western Blotting Market Outlook, By Antibodies & Conjugates (2023-2034) ($MN)
  • Table 6 Global Western Blotting Market Outlook, By Kits (2023-2034) ($MN)
  • Table 7 Global Western Blotting Market Outlook, By Membranes & Filter Papers (2023-2034) ($MN)
  • Table 8 Global Western Blotting Market Outlook, By Other Consumables (2023-2034) ($MN)
  • Table 9 Global Western Blotting Market Outlook, By Instruments (2023-2034) ($MN)
  • Table 10 Global Western Blotting Market Outlook, By Blotting Systems (2023-2034) ($MN)
  • Table 11 Global Western Blotting Market Outlook, By Electrophoresis Instruments (2023-2034) ($MN)
  • Table 12 Global Western Blotting Market Outlook, By Imagers (2023-2034) ($MN)
  • Table 13 Global Western Blotting Market Outlook, By Other Products (2023-2034) ($MN)
  • Table 14 Global Western Blotting Market Outlook, By Application (2023-2034) ($MN)
  • Table 15 Global Western Blotting Market Outlook, By Clinical Diagnostics (2023-2034) ($MN)
  • Table 16 Global Western Blotting Market Outlook, By Lyme Disease (2023-2034) ($MN)
  • Table 17 Global Western Blotting Market Outlook, By Hepatitis (2023-2034) ($MN)
  • Table 18 Global Western Blotting Market Outlook, By Human Immunodeficiency Virus (HIV) (2023-2034) ($MN)
  • Table 19 Global Western Blotting Market Outlook, By Other Clinical Diagnostics (2023-2034) ($MN)
  • Table 20 Global Western Blotting Market Outlook, By Food & Beverages (2023-2034) ($MN)
  • Table 21 Global Western Blotting Market Outlook, By Other Applications (2023-2034) ($MN)
  • Table 22 Global Western Blotting Market Outlook, By End User (2023-2034) ($MN)
  • Table 23 Global Western Blotting Market Outlook, By Hospitals (2023-2034) ($MN)
  • Table 24 Global Western Blotting Market Outlook, By Biopharmaceutical & Biotechnology Companies (2023-2034) ($MN)
  • Table 25 Global Western Blotting Market Outlook, By Academic & Research Institutes (2023-2034) ($MN)
  • Table 26 Global Western Blotting Market Outlook, By Other End Users (2023-2034) ($MN)
  • Table 27 North America Western Blotting Market Outlook, By Country (2023-2034) ($MN)
  • Table 28 North America Western Blotting Market Outlook, By Product (2023-2034) ($MN)
  • Table 29 North America Western Blotting Market Outlook, By Consumables (2023-2034) ($MN)
  • Table 30 North America Western Blotting Market Outlook, By Reagents & Buffers (2023-2034) ($MN)
  • Table 31 North America Western Blotting Market Outlook, By Antibodies & Conjugates (2023-2034) ($MN)
  • Table 32 North America Western Blotting Market Outlook, By Kits (2023-2034) ($MN)
  • Table 33 North America Western Blotting Market Outlook, By Membranes & Filter Papers (2023-2034) ($MN)
  • Table 34 North America Western Blotting Market Outlook, By Other Consumables (2023-2034) ($MN)
  • Table 35 North America Western Blotting Market Outlook, By Instruments (2023-2034) ($MN)
  • Table 36 North America Western Blotting Market Outlook, By Blotting Systems (2023-2034) ($MN)
  • Table 37 North America Western Blotting Market Outlook, By Electrophoresis Instruments (2023-2034) ($MN)
  • Table 38 North America Western Blotting Market Outlook, By Imagers (2023-2034) ($MN)
  • Table 39 North America Western Blotting Market Outlook, By Other Products (2023-2034) ($MN)
  • Table 40 North America Western Blotting Market Outlook, By Application (2023-2034) ($MN)
  • Table 41 North America Western Blotting Market Outlook, By Clinical Diagnostics (2023-2034) ($MN)
  • Table 42 North America Western Blotting Market Outlook, By Lyme Disease (2023-2034) ($MN)
  • Table 43 North America Western Blotting Market Outlook, By Hepatitis (2023-2034) ($MN)
  • Table 44 North America Western Blotting Market Outlook, By Human Immunodeficiency Virus (HIV) (2023-2034) ($MN)
  • Table 45 North America Western Blotting Market Outlook, By Other Clinical Diagnostics (2023-2034) ($MN)
  • Table 46 North America Western Blotting Market Outlook, By Food & Beverages (2023-2034) ($MN)
  • Table 47 North America Western Blotting Market Outlook, By Other Applications (2023-2034) ($MN)
  • Table 48 North America Western Blotting Market Outlook, By End User (2023-2034) ($MN)
  • Table 49 North America Western Blotting Market Outlook, By Hospitals (2023-2034) ($MN)
  • Table 50 North America Western Blotting Market Outlook, By Biopharmaceutical & Biotechnology Companies (2023-2034) ($MN)
  • Table 51 North America Western Blotting Market Outlook, By Academic & Research Institutes (2023-2034) ($MN)
  • Table 52 North America Western Blotting Market Outlook, By Other End Users (2023-2034) ($MN)
  • Table 53 Europe Western Blotting Market Outlook, By Country (2023-2034) ($MN)
  • Table 54 Europe Western Blotting Market Outlook, By Product (2023-2034) ($MN)
  • Table 55 Europe Western Blotting Market Outlook, By Consumables (2023-2034) ($MN)
  • Table 56 Europe Western Blotting Market Outlook, By Reagents & Buffers (2023-2034) ($MN)
  • Table 57 Europe Western Blotting Market Outlook, By Antibodies & Conjugates (2023-2034) ($MN)
  • Table 58 Europe Western Blotting Market Outlook, By Kits (2023-2034) ($MN)
  • Table 59 Europe Western Blotting Market Outlook, By Membranes & Filter Papers (2023-2034) ($MN)
  • Table 60 Europe Western Blotting Market Outlook, By Other Consumables (2023-2034) ($MN)
  • Table 61 Europe Western Blotting Market Outlook, By Instruments (2023-2034) ($MN)
  • Table 62 Europe Western Blotting Market Outlook, By Blotting Systems (2023-2034) ($MN)
  • Table 63 Europe Western Blotting Market Outlook, By Electrophoresis Instruments (2023-2034) ($MN)
  • Table 64 Europe Western Blotting Market Outlook, By Imagers (2023-2034) ($MN)
  • Table 65 Europe Western Blotting Market Outlook, By Other Products (2023-2034) ($MN)
  • Table 66 Europe Western Blotting Market Outlook, By Application (2023-2034) ($MN)
  • Table 67 Europe Western Blotting Market Outlook, By Clinical Diagnostics (2023-2034) ($MN)
  • Table 68 Europe Western Blotting Market Outlook, By Lyme Disease (2023-2034) ($MN)
  • Table 69 Europe Western Blotting Market Outlook, By Hepatitis (2023-2034) ($MN)
  • Table 70 Europe Western Blotting Market Outlook, By Human Immunodeficiency Virus (HIV) (2023-2034) ($MN)
  • Table 71 Europe Western Blotting Market Outlook, By Other Clinical Diagnostics (2023-2034) ($MN)
  • Table 72 Europe Western Blotting Market Outlook, By Food & Beverages (2023-2034) ($MN)
  • Table 73 Europe Western Blotting Market Outlook, By Other Applications (2023-2034) ($MN)
  • Table 74 Europe Western Blotting Market Outlook, By End User (2023-2034) ($MN)
  • Table 75 Europe Western Blotting Market Outlook, By Hospitals (2023-2034) ($MN)
  • Table 76 Europe Western Blotting Market Outlook, By Biopharmaceutical & Biotechnology Companies (2023-2034) ($MN)
  • Table 77 Europe Western Blotting Market Outlook, By Academic & Research Institutes (2023-2034) ($MN)
  • Table 78 Europe Western Blotting Market Outlook, By Other End Users (2023-2034) ($MN)
  • Table 79 Asia Pacific Western Blotting Market Outlook, By Country (2023-2034) ($MN)
  • Table 80 Asia Pacific Western Blotting Market Outlook, By Product (2023-2034) ($MN)
  • Table 81 Asia Pacific Western Blotting Market Outlook, By Consumables (2023-2034) ($MN)
  • Table 82 Asia Pacific Western Blotting Market Outlook, By Reagents & Buffers (2023-2034) ($MN)
  • Table 83 Asia Pacific Western Blotting Market Outlook, By Antibodies & Conjugates (2023-2034) ($MN)
  • Table 84 Asia Pacific Western Blotting Market Outlook, By Kits (2023-2034) ($MN)
  • Table 85 Asia Pacific Western Blotting Market Outlook, By Membranes & Filter Papers (2023-2034) ($MN)
  • Table 86 Asia Pacific Western Blotting Market Outlook, By Other Consumables (2023-2034) ($MN)
  • Table 87 Asia Pacific Western Blotting Market Outlook, By Instruments (2023-2034) ($MN)
  • Table 88 Asia Pacific Western Blotting Market Outlook, By Blotting Systems (2023-2034) ($MN)
  • Table 89 Asia Pacific Western Blotting Market Outlook, By Electrophoresis Instruments (2023-2034) ($MN)
  • Table 90 Asia Pacific Western Blotting Market Outlook, By Imagers (2023-2034) ($MN)
  • Table 91 Asia Pacific Western Blotting Market Outlook, By Other Products (2023-2034) ($MN)
  • Table 92 Asia Pacific Western Blotting Market Outlook, By Application (2023-2034) ($MN)
  • Table 93 Asia Pacific Western Blotting Market Outlook, By Clinical Diagnostics (2023-2034) ($MN)
  • Table 94 Asia Pacific Western Blotting Market Outlook, By Lyme Disease (2023-2034) ($MN)
  • Table 95 Asia Pacific Western Blotting Market Outlook, By Hepatitis (2023-2034) ($MN)
  • Table 96 Asia Pacific Western Blotting Market Outlook, By Human Immunodeficiency Virus (HIV) (2023-2034) ($MN)
  • Table 97 Asia Pacific Western Blotting Market Outlook, By Other Clinical Diagnostics (2023-2034) ($MN)
  • Table 98 Asia Pacific Western Blotting Market Outlook, By Food & Beverages (2023-2034) ($MN)
  • Table 99 Asia Pacific Western Blotting Market Outlook, By Other Applications (2023-2034) ($MN)
  • Table 100 Asia Pacific Western Blotting Market Outlook, By End User (2023-2034) ($MN)
  • Table 101 Asia Pacific Western Blotting Market Outlook, By Hospitals (2023-2034) ($MN)
  • Table 102 Asia Pacific Western Blotting Market Outlook, By Biopharmaceutical & Biotechnology Companies (2023-2034) ($MN)
  • Table 103 Asia Pacific Western Blotting Market Outlook, By Academic & Research Institutes (2023-2034) ($MN)
  • Table 104 Asia Pacific Western Blotting Market Outlook, By Other End Users (2023-2034) ($MN)
  • Table 105 South America Western Blotting Market Outlook, By Country (2023-2034) ($MN)
  • Table 106 South America Western Blotting Market Outlook, By Product (2023-2034) ($MN)
  • Table 107 South America Western Blotting Market Outlook, By Consumables (2023-2034) ($MN)
  • Table 108 South America Western Blotting Market Outlook, By Reagents & Buffers (2023-2034) ($MN)
  • Table 109 South America Western Blotting Market Outlook, By Antibodies & Conjugates (2023-2034) ($MN)
  • Table 110 South America Western Blotting Market Outlook, By Kits (2023-2034) ($MN)
  • Table 111 South America Western Blotting Market Outlook, By Membranes & Filter Papers (2023-2034) ($MN)
  • Table 112 South America Western Blotting Market Outlook, By Other Consumables (2023-2034) ($MN)
  • Table 113 South America Western Blotting Market Outlook, By Instruments (2023-2034) ($MN)
  • Table 114 South America Western Blotting Market Outlook, By Blotting Systems (2023-2034) ($MN)
  • Table 115 South America Western Blotting Market Outlook, By Electrophoresis Instruments (2023-2034) ($MN)
  • Table 116 South America Western Blotting Market Outlook, By Imagers (2023-2034) ($MN)
  • Table 117 South America Western Blotting Market Outlook, By Other Products (2023-2034) ($MN)
  • Table 118 South America Western Blotting Market Outlook, By Application (2023-2034) ($MN)
  • Table 119 South America Western Blotting Market Outlook, By Clinical Diagnostics (2023-2034) ($MN)
  • Table 120 South America Western Blotting Market Outlook, By Lyme Disease (2023-2034) ($MN)
  • Table 121 South America Western Blotting Market Outlook, By Hepatitis (2023-2034) ($MN)
  • Table 122 South America Western Blotting Market Outlook, By Human Immunodeficiency Virus (HIV) (2023-2034) ($MN)
  • Table 123 South America Western Blotting Market Outlook, By Other Clinical Diagnostics (2023-2034) ($MN)
  • Table 124 South America Western Blotting Market Outlook, By Food & Beverages (2023-2034) ($MN)
  • Table 125 South America Western Blotting Market Outlook, By Other Applications (2023-2034) ($MN)
  • Table 126 South America Western Blotting Market Outlook, By End User (2023-2034) ($MN)
  • Table 127 South America Western Blotting Market Outlook, By Hospitals (2023-2034) ($MN)
  • Table 128 South America Western Blotting Market Outlook, By Biopharmaceutical & Biotechnology Companies (2023-2034) ($MN)
  • Table 129 South America Western Blotting Market Outlook, By Academic & Research Institutes (2023-2034) ($MN)
  • Table 130 South America Western Blotting Market Outlook, By Other End Users (2023-2034) ($MN)
  • Table 131 Middle East & Africa Western Blotting Market Outlook, By Country (2023-2034) ($MN)
  • Table 132 Middle East & Africa Western Blotting Market Outlook, By Product (2023-2034) ($MN)
  • Table 133 Middle East & Africa Western Blotting Market Outlook, By Consumables (2023-2034) ($MN)
  • Table 134 Middle East & Africa Western Blotting Market Outlook, By Reagents & Buffers (2023-2034) ($MN)
  • Table 135 Middle East & Africa Western Blotting Market Outlook, By Antibodies & Conjugates (2023-2034) ($MN)
  • Table 136 Middle East & Africa Western Blotting Market Outlook, By Kits (2023-2034) ($MN)
  • Table 137 Middle East & Africa Western Blotting Market Outlook, By Membranes & Filter Papers (2023-2034) ($MN)
  • Table 138 Middle East & Africa Western Blotting Market Outlook, By Other Consumables (2023-2034) ($MN)
  • Table 139 Middle East & Africa Western Blotting Market Outlook, By Instruments (2023-2034) ($MN)
  • Table 140 Middle East & Africa Western Blotting Market Outlook, By Blotting Systems (2023-2034) ($MN)
  • Table 141 Middle East & Africa Western Blotting Market Outlook, By Electrophoresis Instruments (2023-2034) ($MN)
  • Table 142 Middle East & Africa Western Blotting Market Outlook, By Imagers (2023-2034) ($MN)
  • Table 143 Middle East & Africa Western Blotting Market Outlook, By Other Products (2023-2034) ($MN)
  • Table 144 Middle East & Africa Western Blotting Market Outlook, By Application (2023-2034) ($MN)
  • Table 145 Middle East & Africa Western Blotting Market Outlook, By Clinical Diagnostics (2023-2034) ($MN)
  • Table 146 Middle East & Africa Western Blotting Market Outlook, By Lyme Disease (2023-2034) ($MN)
  • Table 147 Middle East & Africa Western Blotting Market Outlook, By Hepatitis (2023-2034) ($MN)
  • Table 148 Middle East & Africa Western Blotting Market Outlook, By Human Immunodeficiency Virus (HIV) (2023-2034) ($MN)
  • Table 149 Middle East & Africa Western Blotting Market Outlook, By Other Clinical Diagnostics (2023-2034) ($MN)
  • Table 150 Middle East & Africa Western Blotting Market Outlook, By Food & Beverages (2023-2034) ($MN)
  • Table 151 Middle East & Africa Western Blotting Market Outlook, By Other Applications (2023-2034) ($MN)
  • Table 152 Middle East & Africa Western Blotting Market Outlook, By End User (2023-2034) ($MN)
  • Table 153 Middle East & Africa Western Blotting Market Outlook, By Hospitals (2023-2034) ($MN)
  • Table 154 Middle East & Africa Western Blotting Market Outlook, By Biopharmaceutical & Biotechnology Companies (2023-2034) ($MN)
  • Table 155 Middle East & Africa Western Blotting Market Outlook, By Academic & Research Institutes (2023-2034) ($MN)
  • Table 156 Middle East & Africa Western Blotting Market Outlook, By Other End Users (2023-2034) ($MN)